E
Eijun Nishihara
Researcher at Center for Excellence in Education
Publications - 102
Citations - 2596
Eijun Nishihara is an academic researcher from Center for Excellence in Education. The author has contributed to research in topics: Thyroid & Graves' disease. The author has an hindex of 29, co-authored 96 publications receiving 2269 citations. Previous affiliations of Eijun Nishihara include Nagasaki University.
Papers
More filters
Journal ArticleDOI
Clinical characteristics of 852 patients with subacute thyroiditis before treatment
Eijun Nishihara,Hidemi Ohye,Nobuyuki Amino,Kazuna Takata,Takeshi Arishima,Takumi Kudo,Mitsuru Ito,Sumihisa Kubota,Shuji Fukata,Akira Miyauchi +9 more
TL;DR: Subacute thyroiditis (SAT) is a transient inflammatory disease of the thyroid that developed most often in female patients aged 40 to 50 years, with significant seasonal clusters during summer to early autumn.
Journal ArticleDOI
Distinct Clinical, Serological, and Sonographic Characteristics of Hashimoto’s Thyroiditis Based with and without IgG4-Positive Plasma Cells
Yaqiong Li,Eijun Nishihara,Mitsuyoshi Hirokawa,Emiko Taniguchi,Akira Miyauchi,Kennichi Kakudo +5 more
TL;DR: Analysis of the immunophenotypic features of IgG4 in 70 cases of Hashimoto's autoimmune thyroiditis patients to clarify the histopathological and clinical characteristics of the patients with IgG 4 thyroiditis demonstrated to be distinct entities.
Journal ArticleDOI
Ontogenetic Changes in the Expression of Estrogen Receptor α and β in Rat Pituitary Gland Detected by Immunohistochemistry
Eijun Nishihara,Yuji Nagayama,Satoshi Inoue,Hisahiko Hiroi,Masami Muramatsu,Shunichi Yamashita,Takehiko Koji +6 more
TL;DR: The purpose of this study was to determine ontogenetic expression of two types of ERs (ERα and ERβ) in the pituitary using specific antibodies, monoclonal antibody (1D5) for ERα and polyclonal antibody generated against ERβ.
Journal ArticleDOI
Methimazole-Induced Agranulocytosis in Patients with Graves' Disease Is More Frequent with an Initial Dose of 30 mg Daily than with 15 mg Daily
Kazuna Takata,Sumihisa Kubota,Shuji Fukata,Takumi Kudo,Eijun Nishihara,Mitsuru Ito,Nobuyuki Amino,Akira Miyauchi +7 more
TL;DR: It is very likely that MMI-induced agranulocytosis occurs with a larger dosage of MMI and is dose related, considering both the effectiveness and the risk of serious side effects.
Journal ArticleDOI
TSH-suppressive doses of levothyroxine are required to achieve preoperative native serum triiodothyronine levels in patients who have undergone total thyroidectomy
Mitsuru Ito,Akira Miyauchi,Shinji Morita,Takumi Kudo,Eijun Nishihara,Minoru Kihara,Yuuki Takamura,Yasuhiro Ito,Kaoru Kobayashi,Akihiro Miya,Sumihisa Kubota,Nobuyuki Amino +11 more
TL;DR: Serum FT(3) levels during postoperative L-T(4) therapy were equivalent to the preoperative levels in patients with moderately suppressed TSH levels, indicating that a moderately TSH-suppressive dose of L- tsh-4 is required to achieve the preoperatively native serum T(3).